Skip to main content

30.04.2018 | Review Article | Ausgabe 6/2018 Open Access

Netherlands Heart Journal 6/2018

Optimal duration of dual antiplatelet therapy for coronary artery disease

Netherlands Heart Journal > Ausgabe 6/2018
W. J. Kikkert, P. Damman


The optimal duration of dual antiplatelet therapy (DAPT) for stable coronary artery disease and acute coronary syndrome is a complex decision. We review current literature on standard duration DAPT versus short duration DAPT (6 months or shorter) or extended duration DAPT (>12 months) after percutaneous coronary intervention with drug-eluting stent placement, and prolonged treatment after 12 months in acute coronary syndrome. Current guideline recommendations are summarised, including the use of risk scores for ischaemic and bleeding risk assessment. Because of the limitations of current risk scores, we propose multiple patient-related and procedure-related factors for the ischaemic and bleeding risk assessment aiding in personalised DAPT duration.
Über diesen Artikel

Weitere Artikel der Ausgabe 6/2018

Netherlands Heart Journal 6/2018 Zur Ausgabe

Image Puzzle – Question

Cough up your lungs


Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.